Foghorn Therapeutics Inc (FHTX) stock news · rev $30.9M
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
This FHTX news page leads with what Foghorn Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for FHTX yet. We will not pad this page with generic market recap.
Latest reported FHTX revenue for 2025-12-31 was $30.9M. Net income was -$74.3M. Revenue was up 36.8% from 2024-12-31 to 2025-12-31. FHTX currently screens at market cap $237.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FHTX stock page; for the tape open the quote page.
FHTX stock news FAQ
What are FHTX's latest revenue and net income?
Latest cached Foghorn Therapeutics Inc (FHTX) revenue for Dec 31, 2025 was $30.9M. Net income was -$74.3M. Statements: https://lician.com/financials/fhtx
How did FHTX revenue change from the prior cached period?
Cached Foghorn Therapeutics Inc (FHTX) revenue was up 36.8% from $22.6M (Dec 31, 2024) to $30.9M (Dec 31, 2025). Statements: https://lician.com/financials/fhtx
What is FHTX's market cap?
Foghorn Therapeutics Inc (FHTX) market cap is $237.8M on the latest cached fundamentals snapshot.
What kind of company is FHTX?
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Where is FHTX stock news listed?
Cached stock news for Foghorn Therapeutics Inc (FHTX) is listed at https://lician.com/news/fhtx. Filings: https://lician.com/sec/fhtx
Not investment advice.